RE: Chronic obstructive pulmonary disease exacerbation frequency and severity

International Journal of COPD

Volumn 8, Issue , 2013, Pages 535-

  Motegi, Takashi ^a   Jones, Rupert C ^b   Kida, Kozui ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; OXYGEN;

AGE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; EXERCISE; FORCED EXPIRATORY VOLUME; HEALTH CARE SYSTEM; HEALTH SERVICE; HUMAN; LETTER; MEDICAL HISTORY; OUTPATIENT; OXYGEN THERAPY; RISK FACTOR; SMOKING; SPIROMETRY;

EID: 84887326508     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S53318     Document Type: Letter

References (5)

1. Motegi T, Jones RC, Ishii T, et al. A comparison of three multidimensional indices of COPD severity as predictors of future exacerbations. Int J Chron Obstruct Pulmon Dis. 2013;8:259-271.
2. Calverley PM, Anderson JA, Celli B, et al; TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356:775-789.
3. Tashkin DP, Celli B, Senn S, et al; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359:1543-1554.
4. Hurst JR, Vestbo J, Anzueto A, et al; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128-1138.
5. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187: 347-365.